CERo Therapeutics Provides Shareholder Update [Yahoo! Finance]
CERo Therapeutics Provides Shareholder Update
CERo Therapeutics Announces Biotech Industry Veteran Eric Francois to Join its Board of Directors
CERo Therapeutics to Present Late-Breaking Oral Poster Session Highlighting Interim Phase 1 Data from CERTAIN-T Trial Highlighting Platelet Transfusion Independence in a High-Risk MDS/AML Patient [Yahoo! Finance]
CERo Therapeutics to Present Late-Breaking Oral Poster Session Highlighting Interim Phase 1 Data from CERTAIN-T Trial Highlighting Platelet Transfusion Independence in a High-Risk MDS/AML Patient